Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Krause

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Torben Krause, Hanna Bonnekoh, Amrei Dilling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 17, 2021
A distinctive bullous skin reaction associated with enfortumab vedotin-ejfv treatment for metastatic urothelial cancer: A case reportTorben Krause, Hanna Bonnekoh, Amrei Dilling, et al.
Nutrients|September 9, 2023
Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic StrategyKatrin Witte, Kerstin Wolk, Ellen Witte-Händel, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2015
Altered B-cell subsets and functional B-cell defects in selective IgM deficiencyAngela Mensen, Torben Krause, Leif Gunnar Hanitsch, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2022
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativaRobert Sabat, Deimantė Šimaitė, Johann Eli Gudjonsson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Torben Krause, Hanna Bonnekoh, Amrei Dilling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 17, 2021
A distinctive bullous skin reaction associated with enfortumab vedotin-ejfv treatment for metastatic urothelial cancer: A case reportTorben Krause, Hanna Bonnekoh, Amrei Dilling, et al.
Nutrients|September 9, 2023
Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic StrategyKatrin Witte, Kerstin Wolk, Ellen Witte-Händel, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2015
Altered B-cell subsets and functional B-cell defects in selective IgM deficiencyAngela Mensen, Torben Krause, Leif Gunnar Hanitsch, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2022
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativaRobert Sabat, Deimantė Šimaitė, Johann Eli Gudjonsson, et al.
Pageof 1